Naphthalene-containing mothballs can cause methemoglobinemia on inhalation. We describe a mother with hemolytic anemia and methemoglobinemia associated with elevated levels of naphthalene following exposure to mothballs. Her newborn infant had identical symptoms requiring mechanical ventilation and an exchange transfusion for resolution.
INTRODUCTION
Most neonates admitted to the intensive care unit with cyanosis unresponsive to supplemental oxygen have either cardiovascular or parenchymal lung disease. A minority will have methemoglobinemia, readily detectable by the persistent chocolatebrown appearance of the blood when exposed to air. We present an infant born with methemoglobinemia due to antepartum maternal naphthalene inhalation from mothballs.
CASE REPORT
A 15-year-old primigravid African-American woman, blood group O, Rh-positive with negative antibody screen, presented with preterm labor at 36 weeks gestation. On admission, she was diagnosed with a hemolytic anemia of unknown etiology and had an unremarkable past medical history. Following oxytocin augmentation for fetal distress she vaginally delivered a hypotonic, cyanotic and apneic male infant. He received bag-mask ventilation with spontaneous breathing but persistent cyanosis giving Apgars of 2 at 1 minute and 6 at 5 minutes. The passage of dark urine, together with cyanosis, prompted transfer of the infant to the intensive care nursery.
He was symmetrical for gestational age with normal vital signs. The infant was alert with no respiratory distress, a normal chest Xray and arterial blood gas. However, his appearance was pale and cyanotic with a pulse-oximetry reading of 84% saturation, despite supplemental blow-by 100% oxygen. His hematocrit was 30% and reticulocyte count 7.9%. There were 136 nucleated red blood cells (RBCs) per 100 white blood cells and the blood smear showed evidence of acute hemolysis but no Heinz bodies. The baby's blood type was group O, Rh-positive with negative antibody screen and a total bilirubin of 6 mg/dl (102 mmol/l) at birth. Urinalysis revealed moderate blood/hemoglobin, proteinuria, with rare RBCs, and no myoglobin. Methemoglobin levels were 11.3 (normal <1%) and 1.3% in the neonatal and maternal samples, respectively.
At 7 hours of age, increasing tachypnea and oxygen requirement necessitated intubation and mechanical ventilation with 100% oxygen. He was extubated to room air at 40 hours of age by which time his methemoglobin level had decreased to 4.8%. However, his total bilirubin continued to rise, despite the initiation of double phototherapy with super-blue light bulbs (General Electric; F20 T12/BB) at birth. It reached 20 mg/dl (342 mmol/l) with an end-tidal carbon monoxide (ETCOc, Natus Inc.; 9,10) measured 8.8 ppm (normal <2 ppm) at 50 hours of age, indicating brisk hemolysis. A double-volume exchange transfusion was performed, which lowered his bilirubin to 10 mg/dl (171 mmol/l) although there was a subsequent rebound after exchange to a maximum level of 14 mg/dl (239 mmol/l). He was discharged home in healthy condition at 16 days of age.
We suspected a transplacentally acquired toxin because both the mother and the infant had a new onset hemolytic anemia. Following persistent questioning of the family, it transpired that an entire box of moth flakes (100% refined naphthalene) had spilt into a heating vent approximately 1 week prior to delivery. The resultant fumes had necessitated the windows remaining open despite subzero external environmental temperatures. Naphthalene was not detected in the infant's blood after exchange transfusion, and no urine samples were available prior to this procedure. However, a urinary metabolite of naphthalene was found to be present in the mother's urine sample from admission. Both mother and infant were well 1 year later.
DISCUSSION
Methemoglobinemia (methemoglobin concentration >1%) is an important differential diagnosis in all cyanotic patients. 1 (Table 1) Methemoglobin is formed by the oxidation of ferrous (Fe 2 þ ) hemoglobin to ferric (Fe 3 þ ) hemoglobin and cannot bind oxygen. It produces marked cyanosis even at concentrations that are not life threatening. Additionally, due to the spectrophotometric absorbance properties of methemoglobin, readings on pulseoximetry trend toward 85%. 2 However, measurement of PO 2 is not affected by the presence of methemoglobin. Therefore, a pulseoximeter reading that is inconsistent with oxygen saturation calculated using the PO 2 measurement is suggestive of methemoglobinemia. This infant's ventilation was managed using trends in both PO 2 and pulse oximetry while recognizing the disparity between them. A major potential cause of methemoglobinemia among neonates is nitric oxide administration for treatment of hypoxic respiratory failure. 3 Infants are more sensitive than adults to methemoglobin-producing agents due to lower levels of NADH-dependent methemoglobin reductase activity, which may be more pronounced in preterm infants. 4 Naphthalene is absorbed following oral, dermal, and inhalation exposure and its association with hemolytic anemia is well described in most textbooks. However, the association of methemoglobinemia with naphthalene exposure is based on temporal linkage and not proven by assay. Although the parent compound is devoid of hemolytic properties, its oxidative metabolite, alpha-naphthol, possesses potent hemolytic activity resulting in hemoglobinuria and methemoglobinemia. A single previous report of suspected transplacental naphthalene poisoning exists in the literature 5 and a case series of 21 newborns was also described who developed severe hemolysis after inhalation exposure to naphthalene-containing mothballs. 6 Naphthalene levels were not available in this era. Following these reports, most manufacturers have substituted the chemical, paradichlorobenzene, which is less toxic, for naphthalene as the active compound in most mothball and diaper pail deodorizer products.
The treatment of methemoglobin due to a toxic exposure is generally supportive by correcting anemia, exchange transfusion in cases of severe poisoning and removal of the toxin. 1 The use of methylene blue, a soluble guanylate cyclase inhibitor, should be avoided in infants, as it can cause methemoglobinemia and hemolytic anemia. 1 This case is the first documenting exposure by drug assay rather than history alone. We speculate that the enormous surface area of the moth flakes combined with heat, led to a massive inhalation exposure of naphthalene, as evident by ongoing hemolysis and presence of the metabolite in the infant's mother 1 week after the initial exposure. Methemoglobinemia causing cyanosis and respiratory failure is unusual in the perinatal period and maternal poisoning should be considered. 
